Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy

Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy

US Patent 12023305 · Granted Jul 2, 2024

Estimated economic value: $59,068,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard ant2025
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard ant2025
Use of cannabidiol in the treatment of tuberous sclerosis complex2025
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2024
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2024
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2023
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2023
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2022
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV2022
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2021
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2021
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy2020